-
EP3227330
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3227330
| EP3227330 - TDP-43-BINDING POLYPEPTIDES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 15.12.2023 Database last updated on 22.05.2024 | |
| Former | Grant of patent is intended Status updated on 11.08.2023 | ||
| Former | Examination is in progress Status updated on 01.08.2023 | ||
| Former | Grant of patent is intended Status updated on 30.03.2023 | ||
| Former | Examination is in progress Status updated on 29.06.2019 | ||
| Former | Request for examination was made Status updated on 08.09.2017 | ||
| Former | The international publication has been made Status updated on 22.06.2017 | Most recent event Tooltip | 15.12.2023 | (Expected) grant | published on 17.01.2024 [2024/03] | Applicant(s) | For all designated states Université Laval 2325 rue de l'Université Québec, Québec G1V 0A6 / CA | [2017/41] | Inventor(s) | 01 /
JULIEN, Jean-Pierre 985 Grande-Allée Ouest Québec, Québec G1S 1E1 / CA | 02 /
GRAVEL, Claude 3520 Pincourt Québec, Québec G2B 2E3 / CA | 03 /
POZZI, Silvia 90 rue de Maisonneuve Québec, Québec G1R 2C3 / CA | [2017/41] | Representative(s) | Cabinet Becker et Associés 25, rue Louis le Grand 75002 Paris / FR | [2017/41] | Application number, filing date | 15864525.9 | 07.12.2015 | [2017/41] | WO2015CA51280 | Priority number, date | CA20142874083 | 05.12.2014 Original published format: CA 2874083 | US201462088012P | 05.12.2014 Original published format: US 201462088012 P | [2017/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016086320 | Date: | 09.06.2016 | Language: | EN | [2016/23] | Type: | A1 Application with search report | No.: | EP3227330 | Date: | 11.10.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.06.2016 takes the place of the publication of the European patent application. | [2017/41] | Type: | B1 Patent specification | No.: | EP3227330 | Date: | 17.01.2024 | Language: | EN | [2024/03] | Search report(s) | International search report - published on: | CA | 09.06.2016 | (Supplementary) European search report - dispatched on: | EP | 27.09.2018 | Classification | IPC: | C07K16/18, A61K39/395, A61P25/16, A61P25/28, C07K16/46, C12N15/13, C12N15/864, C12N5/10 | [2017/41] | CPC: |
C07K16/18 (EP,US);
A61P21/02 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P9/10 (EP);
C12N15/86 (US);
A61K48/00 (US);
C07K2317/24 (US);
C07K2317/35 (US);
C07K2317/52 (US);
C07K2317/54 (US);
C07K2317/55 (US);
C07K2317/569 (US);
C07K2317/622 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/41]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | TDP-43-BINDENDE POLYPEPTIDE ZUR BEHANDLUNG NEURODEGENERATIVER ERKRANKUNGEN | [2017/41] | English: | TDP-43-BINDING POLYPEPTIDES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | [2017/41] | French: | POLYPEPTIDES DE LIAISON À TDP-43 UTILES POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES | [2017/41] | Entry into regional phase | 21.06.2017 | National basic fee paid | 21.06.2017 | Search fee paid | 21.06.2017 | Designation fee(s) paid | 21.06.2017 | Examination fee paid | Examination procedure | 21.06.2017 | Examination requested [2017/41] | 21.06.2017 | Date on which the examining division has become responsible | 16.04.2019 | Amendment by applicant (claims and/or description) | 03.07.2019 | Despatch of a communication from the examining division (Time limit: M04) | 04.11.2019 | Reply to a communication from the examining division | 21.02.2020 | Despatch of a communication from the examining division (Time limit: M04) | 24.06.2020 | Reply to a communication from the examining division | 23.09.2020 | Despatch of a communication from the examining division (Time limit: M06) | 31.03.2021 | Reply to a communication from the examining division | 17.06.2021 | Despatch of a communication from the examining division (Time limit: M04) | 14.10.2021 | Reply to a communication from the examining division | 28.02.2022 | Despatch of a communication from the examining division (Time limit: M04) | 24.06.2022 | Reply to a communication from the examining division | 31.03.2023 | Communication of intention to grant the patent | 01.08.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 01.08.2023 | Fee for grant paid | 01.08.2023 | Fee for publishing/printing paid | 21.08.2023 | Communication of intention to grant the patent | 11.12.2023 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 18.12.2017 | Renewal fee patent year 03 | 10.12.2018 | Renewal fee patent year 04 | 10.12.2019 | Renewal fee patent year 05 | 10.12.2020 | Renewal fee patent year 06 | 06.12.2021 | Renewal fee patent year 07 | 23.12.2022 | Renewal fee patent year 08 | 09.10.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] - LINDA K KWONG ET AL, "Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins", ACTA NEUROPATHOLOGICA COMMUNICATIONS, BIOMED CENTRAL LTD, LONDON, UK, (20140331), vol. 2, no. 1, doi:10.1186/2051-5960-2-33, ISSN 2051-5960, page 33, XP021182567 [X] 1-10,12-15 * abstract * DOI: http://dx.doi.org/10.1186/2051-5960-2-33 | [A] - GENDRON T F ET AL, "Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration", NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 36, no. 2, doi:10.1111/J.1365-2990.2010.01060.X, ISSN 1365-2990, (20100401), pages 97 - 112, (20100323), XP002658541 [A] 1-10,12-15 * the whole document * DOI: http://dx.doi.org/10.1111/J.1365-2990.2010.01060.X | International search | [X]WO2012174666 (UNIV LAVAL [CA], et al) [X] 24, 27-36, 39-43 *see the entire document*; | [A] - SWARUP, V. et al., "Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor KB-mediated pathogenic pathways.", J. Exp. Med., (20111121), vol. 208, no. 12, ISSN 0022-1007, pages 2429 - 2447, XP055124401 [A] 1-43 * . *see the entire document* DOI: http://dx.doi.org/10.1073/pnas.0900688106 | Examination | - MATHIEU DONDELINGER ET AL, "Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition", FRONTIERS IN IMMUNOLOGY, (20181016), vol. 9, doi:10.3389/fimmu.2018.02278, pages 1 - 15, XP055572450 DOI: http://dx.doi.org/10.3389/fimmu.2018.02278 | - SILVIA POZZI ET AL, "Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology", THE JOURNAL OF CLINICAL INVESTIGATION, GB, (20190225), vol. 129, no. 4, doi:10.1172/JCI123931, ISSN 0021-9738, pages 1581 - 1595, XP055657665 DOI: http://dx.doi.org/10.1172/JCI123931 | by applicant | WO8605807 | JPS6296086 | US4683195 | WO8704462 | EP0251744 | EP0258067 | US4857467 | WO8910036 | WO8910404 | WO9001063 | EP0361991 | EP0387319 | US4980286 | WO9106657 | WO9412650 | WO9629411 | US5576195 | US5641670 | WO9852976 | US5846818 | WO2012174666 | - V. SWARUP et al., J. Exp. Med., (20110000), vol. 208, pages 2429 - 2447 | - "GenBank", Database accession no. AAA72759 | - "NCBI", Database accession no. M62399.1 | - BATZER et al., Nucleic Acid Res, (19910000), vol. 19, page 5081 | - WUWU, J. Biol. Chem., (19870000), vol. 262, pages 4429 - 4432 | - REITER et al., Nat Biotechnol, (19960000), vol. 14, pages 1239 - 1245 | - MILLER et al., Protein Eng Des Sel., (20100700), vol. 23, no. 7, pages 549 - 57 | - IGAWA et al., MAbs, (20110500), vol. 3, no. 3, pages 243 - 5 | - PERCHIACCATESSIER, Annu Rev Chem Biomol Eng, (20120000), vol. 3, pages 263 - 86 | - LILJEBLAD et al., Glyco J, (20000000), vol. 17, pages 323 - 329 | - HEELEY, Endocr Res, (20020000), vol. 28, pages 217 - 229 | - OHTSUKA et al., J. Biol. Chem., (19850000), vol. 260, pages 2605 - 2608 | - ROSSOLINI et al., Mol. Cell. Probes, (19940000), vol. 8, pages 91 - 98 | - NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), vol. 48, page 443 | - PEARSONLIPMAN, Proc. Nat'l. Acad. Sci. USA, (19880000), vol. 85, page 2444 | - ALTSCHUL et al., Nuc. Acids Res., (19970000), vol. 25, pages 3389 - 3402 | - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410 | - PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 89, pages 10915 - 596 | - KARLINALTSCHUL, Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 5873 - 5787 | - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525 | - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 329 | - BEBBINGTON et al., Bio/technology, (19920000), vol. 10, page 169 | - Biblia and Robinson Biotechnol, (19950000), vol. 11, page 1 | - KOLLER et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 8932 - 8935 | - ZIJLSTRA et al., Nature, (19890000), vol. 342, pages 435 - 438 | - RANGERPEPPAS, J., Macromol. Sci. Rev. Macromol. Chem., (19830000), vol. 23, pages 61 - 12 | - HUNKAPILLER et al., Nature, (19840000), vol. 310, pages 105 - 111 | - CARLSON et al., Biotechnol. Adv., (20120000), vol. 30, pages 1185 - 1194 | - BECKERGUARENTE, Methods Enzymol., (19900000), vol. 194, page 182 | - MAUNDRELL, J. Biol. Chem., (19900000), vol. 265, pages 10857 - 10864 | - HOFFMANWINSTON, Genetics, (19900000), vol. 124, pages 807 - 816 | - GLEESON et al., J. Gen. Microbiol., (19860000), vol. 132, pages 3459 - 3465 | - SEIFTER et al., Meth. Enzymol., (19900000), vol. 182, pages 626 - 646 | - RATTAN et al., Ann. N.Y. Acad. Sci., (19920000), vol. 663, pages 48 - 62 | - LANGER, Science, (19900000), vol. 249, pages 1527 - 1533 | - SAUDEK et al., N. Engl. J. Med., (19890000), vol. 321, pages 574 - 365 | - SEFTON, CRC Crit. Ref. Biomed. Eng., (19870000), vol. 14, page 201 | - BUCHWALD et al., Surgery, (19800000), vol. 88, page 507 | - GOODSON, Medical Applications of Controlled Release, (19840000), vol. 2, pages 115 - 138 | - LEVY et al., Science, (19850000), vol. 228, page 190 | - DURING et al., Ann. Neurol., (19890000), vol. 25, page 351 | - HOWARD et al., J. Neurosurg., (19890000), vol. 71, page 105 | - JOLIOT et al., Proc. Natl. Acad. Sci. USA, (19910000), vol. 88, pages 1864 - 1868 | - PATEL et al., Molecular Therapy, (20140000), vol. 22, no. 3, pages 498 - 510 | - SWARUP et al., Brain, (20110000), vol. 134, pages 2610 - 2626 | - WEGORZEWSKA et al., Proc. Natl. Acad. Sci. U.S.A., (20090000), vol. 106, pages 18809 - 14 | - GURNEY et al., Science, (19940000), vol. 264, pages 772 - 75 | - SHAN et al., Neuropharmacol. Letters, (20090000), vol. 458, pages 70 - 74 | - WILS et al., Proc. Natl. Acad. Sci. USA., (20100000), vol. 106, pages 3858 - 63 | - DUCHENSTRICH, "J. Neurol. Neurosurg", Psychiatry, (19680000), vol. 31, pages 535 - 42 | - DENNISCITRON, Neuroscience, (20090000), vol. 185, pages 745 - 50 | - SGAZ et al., J Clin invest., (20110000), vol. 121, no. 2, pages 726 - 38 | - CACCAMO et al., Am J Pathol, (20120000), vol. 180, no. l, pages 293 - 302 | - CANNON et al., Acta Neuropathol, (20120000), vol. 123, no. 6, pages 807 - 23 | - CUSTER et al., Hum Moi Genet, (20100000), vol. 19, no. 9, pages 1741 - 55 | - TATOM et al., oL Ther, (20090000), vol. 17, pages 607 - 613 | - HASEGAWA et al., Ann Neurol, (20080000), vol. 64, pages 60 - 70 | - CAREYSUNDBERG, Advanced Organic Chemistry, Plenum Press, (19920000), vol. A,B | - PATEL et al., Mol Ther, (20140000), vol. 22, no. 3, pages 498 - 510 | - MCCARTY et al., Gene Ther, (20010000), vol. 8, pages 1248 - 1254 | - RABINOWITZ et al., J Virol, (20020000), vol. 76, pages 791 - 801 |